Search
Fennec Pharmaceuticals Inc
FENCAdd to Watchlist
10.620USD
+0.110+1.05%
Close 09-24 16:00（ET）
368.94MMarket Cap
LossP/E TTM
Fennec Pharmaceuticals Inc (FENC) Revenue Performance
Updated: Jun 30, 2026For the latest quarter, Fennec Pharmaceuticals Inc reported the revenue of 7.26M USD for the period ending 2024-06-30, which came from the top-performing segment, PEDMARK product sales. United States contributed the highest revenue, at 17.87M USD.
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2025
FY2024
FY2023
FY2022
United States
44.64M(100.00%)
47.54M(100.00%)
21.25M(100.00%)
1.53M(100.00%)